If you have bipolar disorder and use cannabis, the care plan should review mood, sleep, medication, substance use, and everyday functioning together. Cannabis may be used for reasons that feel understandable, such as sleep, anxiety, pain, or emotional relief. Those perceived benefits need to be considered alongside possible unwanted effects and the course of the bipolar condition.
The assessment should be specific to your history. It should not rely on a general claim that cannabis is always calming or assume that every mood symptom has one cause. A useful review explains the evidence, considers current safety, and establishes how psychiatric treatment and support for cannabis use will be coordinated.
Recognize a significant change in mood or behavior
The NIMH bipolar disorder guide describes episodes involving changes in mood, energy, activity, and functioning. Tell the clinician about markedly reduced need for sleep, unusually elevated or irritable mood, impulsive behavior, depression, hopelessness, or a substantial change from your usual state.
Seek urgent assessment for escalating agitation, paranoia, hallucinations, major impairment in judgment, or inability to remain safe. Immediate self-harm risk, collapse, severe confusion, a seizure, or another medical emergency requires emergency services. Do not wait to determine whether the change is due to cannabis, a mood episode, medication, or a combination before seeking help when the situation is dangerous.
Review what research can and cannot tell you
A CANMAT task force systematic review found associations between cannabis use and a worse course, symptoms, and functioning in bipolar disorder. The authors also identified limitations in the evidence, including the need for better information about cannabis exposure and comparison groups. This supports taking cannabis use seriously in the clinical review without treating a research association as proof of the cause of an individual episode.
Ask the psychiatrist how that evidence applies to your history and current treatment. A personal report of short-term relief does not establish longer-term benefit or safety. Equally, the conversation should examine what cannabis appears to provide and what support is needed to address those needs through the broader plan. The goal is an informed decision grounded in both evidence and the person’s circumstances.
Map mood episodes and cannabis use across time
Record previous manic, hypomanic, or depressive episodes, hospital admissions, medication changes, and periods of ordinary functioning. Add when cannabis use began, changes in frequency or products, and periods of reduced or absent use. Include other substances and major changes in sleep or daily routine.
Our timeline guide can help organize this account. Ask what the sequence suggests and what remains uncertain. A clinician may need earlier records or follow-up before interpreting the relationship. The timeline should improve the assessment, not become a self-diagnostic exercise or a requirement to explain every past episode perfectly.
Describe the cannabis pattern in enough detail
Tell the clinician about frequency, method of use, products, sources, and changes over time. Bring packaging information if available, while being clear about uncertainty in contents or amounts. Include products obtained through medical routes, CBD products, and other cannabis-related preparations you use.
Describe whether use is planned, whether you use more than intended, and whether attempts to reduce have been difficult. Ask whether a cannabis use disorder assessment is appropriate. Those questions concern control and consequences as well as the effect on mood. A person can need help with the substance pattern even when they believe it began as a way of managing symptoms.
Examine sleep and the reason for use
If cannabis is used for sleep, explain the full pattern: when you use it, when you sleep, how rested you feel, and what happens on days without it. Also describe whether you are tired but unable to sleep or feel unusually energized despite very little sleep. Those experiences can raise different clinical questions.
Ask how sleep will be addressed within bipolar care and any plan to change cannabis use. Do not independently add alcohol, sedatives, or extra medication to settle at night. The clinician needs to review the current mood state and complete substance history. A plan should account for the reason you use cannabis rather than assume that changing use removes every underlying sleep or anxiety concern.
Bring the actual medication history
List all current medicines and how you take them, including missed doses, stopped treatment, extra doses, and products obtained outside usual prescribing. Explain earlier medication trials, benefits, adverse effects, and the reasons changes were made. If more than one clinician prescribes, provide the relevant contact details.
NIMH advises discussing medication changes with a health professional rather than stopping treatment independently. Ask who will review psychiatric medication when cannabis use changes and how symptoms will be monitored. Do not assume that feeling better, sleeping longer, or reducing cannabis means established bipolar treatment is no longer necessary. That decision requires a clinical review of the broader course and risks.
Include other substances and physical health
Tell the team about alcohol, stimulants, benzodiazepines, opioids, nicotine, caffeine, and nonprescription products. Explain substances used to manage the effects of others. If alcohol or benzodiazepine dependence may be present, obtain medical advice before abrupt changes. A plan centered only on cannabis may overlook another immediate medical concern.
Include relevant physical symptoms, medical diagnoses, pain, and recent investigations. The NIMH resource on co-occurring disorders supports a comprehensive view of mental health and substance use. Ask which clinician coordinates the overall picture so that different services do not make decisions from separate, incomplete medication and substance histories.
Address paranoia or other unusual experiences directly
The CDC cannabis and mental health guidance describes anxiety, paranoia, and associations with psychosis. Tell the clinician about unusual beliefs, hallucinations, disorientation, or severe fear, including when they occur relative to cannabis use and mood changes. Do not dismiss them as an expected part of using a particular product.
If symptoms are new, worsening, or affecting safety, seek prompt assessment. A supporter can acknowledge distress without agreeing with a belief they do not share. The clinical team needs to assess the experience and current needs. The person should not be expected to identify the exact cause before obtaining help or be left alone with escalating symptoms while waiting for a routine appointment.
Ask how psychiatric and substance treatment will work together
Identify the clinician responsible for bipolar care and the service providing support for cannabis use. Ask how they will communicate, which changes should be reported to both, and how the treatment goals connect. An integrated plan may involve several professionals, but it should have clear responsibilities and a shared understanding of current priorities.
Our shared care plan guide explains the practical details to establish. Ask what support is available for cravings, routines associated with cannabis, and the needs cannabis has been used to manage. Psychiatric medication review alone may not address the behavioral pattern, while substance treatment should not displace ongoing management of the mood disorder.
Make changes observable and reviewable
Agree what to track with the clinician: sleep, energy, mood, daily activities, medication use, and the cannabis pattern. Keep the record simple enough to maintain. The purpose is to help the team recognize meaningful changes, not to create a demanding surveillance system or rely on a single score.
If symptoms change during a reduction or another change in use, report them. Ask which signs require earlier review and how to get help outside scheduled appointments. Avoid interpreting every uncomfortable day as proof that cannabis is necessary or every improved day as proof that all risks have resolved. The pattern over time and the clinical assessment should guide decisions.
Involve support people with clear roles
With consent, a family member or trusted person may help notice significant changes, attend an appointment, or assist with practical tasks. Agree what information is shared and how concerns can be raised. They should not be expected to diagnose mood episodes, control medication, or manage serious symptoms without professional guidance.
Discuss boundaries around spending, driving, work, travel, or other responsibilities if judgment or functioning is affected. Ask the clinician which arrangements are appropriate and how they will be reviewed. Support should address current needs while preserving autonomy as much as possible, rather than becoming an indefinite system in which relatives monitor every choice.
If a cannabis-based product was recommended for another medical condition, ask the clinicians involved to review that purpose alongside bipolar care. Bring the original plan and describe both benefit and concerns. Coordination should include how the other condition will be managed if the treatment approach changes, rather than leaving the person to reconcile conflicting advice alone.
Keep continuing care in place when you feel more stable
Ask when the next psychiatric and substance-related reviews will occur and what each is intended to assess. If care changes location or provider, confirm that the receiving team has the episode history, medication plan, cannabis timeline, recent risks, and unresolved questions. Do not let a move or a period of improvement create an accidental gap in prescribing or follow-up.
A useful bipolar and cannabis plan combines evidence, an honest personal history, and practical coordination. It should explain how mood stability, substance use, sleep, and everyday functioning will be reviewed together. The aim is a sustainable course of care that can respond to new information while helping the person participate in the life they value.
Sources and further reading
Found a detail that has changed? Tell the editorial team.